These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 25331088)

  • 21. Pathophysiology and management of cardiovascular disease in patients with HIV.
    Nou E; Lo J; Hadigan C; Grinspoon SK
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):598-610. PubMed ID: 26873066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and Ischemic Heart Disease.
    Vachiat A; McCutcheon K; Tsabedze N; Zachariah D; Manga P
    J Am Coll Cardiol; 2017 Jan; 69(1):73-82. PubMed ID: 28057253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.
    Carroll V; Garzino-Demo A
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26121984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
    Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G
    J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of antiretroviral therapy: challenges and needs.
    Moreno S; López Aldeguer J; Arribas JR; Domingo P; Iribarren JA; Ribera E; Rivero A; Pulido F;
    J Antimicrob Chemother; 2010 May; 65(5):827-35. PubMed ID: 20228080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
    Heaton RK; Franklin DR; Ellis RJ; McCutchan JA; Letendre SL; Leblanc S; Corkran SH; Duarte NA; Clifford DB; Woods SP; Collier AC; Marra CM; Morgello S; Mindt MR; Taylor MJ; Marcotte TD; Atkinson JH; Wolfson T; Gelman BB; McArthur JC; Simpson DM; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I; ;
    J Neurovirol; 2011 Feb; 17(1):3-16. PubMed ID: 21174240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid suppression of HIV-RNA is associated with improved control of immune activation in Mozambican adults initiating antiretroviral therapy with low CD4 counts.
    Almeida JM; Letang E; Nhampossa T; Ayala E; David C; Menendez C; Gascon J; Alonso P; Naniche D
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):705-11. PubMed ID: 21091388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.
    Calza L; Colangeli V; Manfredi R; Bon I; Re MC; Viale P
    J Antimicrob Chemother; 2016 Jun; 71(6):1451-65. PubMed ID: 26846208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.
    ; Lodi S; del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Olson A; van Sighem A; Reiss P; Sabin C; Jose S; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Vourli G; Antoniadou A; Dabis F; Vandenhede MA; Costagliola D; Abgrall S; Hernán MA
    AIDS; 2014 Oct; 28(16):2461-73. PubMed ID: 25265230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.
    Mugusi S; Ngaimisi E; Janabi M; Mugusi F; Minzi O; Aris E; Bakari M; Bertilsson L; Burhenne J; Sandstrom E; Aklillu E
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1405-1415. PubMed ID: 30003275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection and coronary heart disease: mechanisms and management.
    Hsue PY; Waters DD
    Nat Rev Cardiol; 2019 Dec; 16(12):745-759. PubMed ID: 31182833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain.
    Simpson KN; Jones WJ; Rajagopalan R; Dietz B
    Clin Drug Investig; 2007; 27(12):807-17. PubMed ID: 18020538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of diabetes mellitus-related comorbidities among patients attending two major HIV clinics in Botswana: a 12-year retrospective cohort study.
    Rankgoane-Pono G; Tshikuka JG; Magafu MGMD; Masupe T; Molefi M; Hamda SG; Setlhare V; Tapera R; Mbongwe B
    BMC Res Notes; 2018 Feb; 11(1):90. PubMed ID: 29391039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.
    Ndumbi P; Falutz J; Pant Pai N; Tsoukas CM
    PLoS One; 2014; 9(4):e94018. PubMed ID: 24710051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.
    Do NT; Phiri K; Bussmann H; Gaolathe T; Marlink RG; Wester CW
    AIDS Res Hum Retroviruses; 2010 Jun; 26(6):685-91. PubMed ID: 20518649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction.
    Pedersen KK; Pedersen M; Trøseid M; Gaardbo JC; Lund TT; Thomsen C; Gerstoft J; Kvale D; Nielsen SD
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):425-33. PubMed ID: 23797689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.
    Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC
    BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicted coronary heart disease risk in croatian HIV infected patients treated with combination antiretroviral therapy.
    Turcinov D; Begovac J
    Coll Antropol; 2011 Mar; 35(1):115-21. PubMed ID: 21667536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.